A Phase 2 interventional study of mirtazapine and placebo in Alcohol Dependence, sponsored by Sahlgrenska University Hospital. Completed at 1 site in Sweden. Open to male participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2009-04-02.
Sponsored by Sahlgrenska University Hospital · Phase 2, Interventional, and Treatment
The purpose of this study is to study the effects of 8 weeks of treatment with mirtazapine on alcohol consumption in alcohol high consuming men. This study is a randomized, double-blind placebo controlled clinical trial with parallel group design(N=59).
1,606 studies on the registry are indexed under Alcoholism; 329 are open to participants now.
This study's enrollment of 59 is below the median of 87 across 1,371 interventional studies indexed under Alcoholism.
Browse Alcoholism studies →Sahlgrenska University Hospital is the lead sponsor of 259 studies on the registry; 68 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
n=29
Drug: mirtazapine
n=30
Drug: placebo
oral tablet, 30 mg daily
oral tablet, 1 daily
Alcohol consumption measured by alcohol diary (units/week).
This study is completed, as verified in Mar 2009. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Sahlgrenska University Hospital